Nokia And Sprint: Great Potential For Turnaround [View article]
It's incredible that a company that only loses money, without any real perspective for turning into profit, gets more love from Wall Street than Nokia, which is clearly swinging into profit.
But then again, CRUS only goes up, while Salesforce.com keep on losing money. Makes no sense whatsoever.
Angela Merkel calls herself "very satisfied" a Cyprus solution has been found and reminds taxpayers cannot save banks (Ireland and Spain say "hi"). "With responsibility on the part of Cyprus, we will ensure that solidarity is provided by the euro are," says EU Commission chief Barroso. Meanwhile, the WSJ reports Cyprus border officials searching bags with orders to confiscate any cash sums over €10K. Just a reminder - Cyprus is a member of the EU. [View news story]
Durão Barroso and his criminal friends destroyed Europe. I hope people who have been voting for these corrupted politicians for the past 30 years are happy with themselves.
Poor cash flow trends for Nokia's (NOK -0.7%) phone business are being masked by the strong performance of a resurgent Nokia Siemens, argues BofA/Merrill, which reiterates an Underperform. Should a spinoff, sale, or IPO of NSN happen following the pending expiration of Nokia and Siemens' JV agreement (as many expect), the firm thinks Nokia's handset cash flow challenges will become more apparent. [View news story]
Cramer Is Now Bullish On 'Old Tech' Stocks Like Intel [View article]
I've been waiting for a crash in INTC for quite some time now. Thanks to Cramer, it seems I'll be able to grab INTC around $14 this year! :-P
I'll keep waiting for that day when INTC will drop 30% after-hours so I can start buying it.
PS: I still remember the Summer of 2011, where Cramer recommended buying RIMM around $50, saying it would popup to $70 in no time. Instead, RIMM went the other way, until $7. At least he got the "No time" part right.
Cisco Systems: Absolutely The Best Tech Bet In 2013? [View article]
These kind of analysis are always very subjective.
I still remember HPQ trading at $35, which had an "Intrinsic Value" of $48 in the summer of 2011... and then it crashed to $26... and then it crashed again to $11... At that time, no analyst was pointing to a value below $37. How well has that worked out?
In Europe is being privatized, including schools, hospitals & water. You must have a strange definition of socialism, that's for sure... or you live in an alternate reality.
A Quick Look At 8 Biotechs Ready To Gain Momentum [View article]
Looks like it was all a big lie after all. I sure know how to pick 'em. After $AMRN, $SPPI collapses. That's it for me. No more stocks. I think I'll try Poker as less luck is required.
Spectrum Pharmaceuticals (SPPI) guides FY13 revenue below Street estimates, now anticipating total revenues in the range of $160M to $180M. Analysts were projecting FY13 revenue to come in at $297M. The company cites a change in ordering patterns of Fusilev and an increase in generic competition in its hospital segment for the shortfall, following the recent stabilization of the folate analog market. Shares remain halted AH. [View news story]
After this, I only see $SPPI trading above $12 four or five years from now, with luck. Shorts are still not covering. Adam F, like most shorts, have bet against $SPPI when the stock was trading around $8. They are still not happy.
Raj has a lot of explaining to do. How did this happen in just 19 days? Was everything he said in the Earnings Release a complete lie? It sure looks that way...
I hope he quits. After this, no investor will ever trust anything he says. I'm long SPPI and I won't sell but this price is perfectly justified. I see it going back to $4... but I'd rather hold now than taking a loss. I feel cheated but I'll wait for 5 decades to recover my money, if I have to.
Spectrum Pharmaceuticals (SPPI) guides FY13 revenue below Street estimates, now anticipating total revenues in the range of $160M to $180M. Analysts were projecting FY13 revenue to come in at $297M. The company cites a change in ordering patterns of Fusilev and an increase in generic competition in its hospital segment for the shortfall, following the recent stabilization of the folate analog market. Shares remain halted AH. [View news story]
I've been defending this stock but I this is inexcusable. Raj lied to every investor and I hope he quits Spectrum as soon as possible. Looks like Adam Feuerstein will be getting his money back after all, as he's been waiting for this day for nearly 2 years now...
Spectrum Pharmaceuticals (SPPI): Q4 EPS of $0.27 beats by $0.01. Revenue of $70.1M beats by $0.22M. (PR) [View news story]
And yet another stock collapses. That's it. I'm officially abandoning the game. I have better luck at Poker than in the Stock Market. Raj lied to us big time. It's sad... but true.
Nokia Will Probably Launch Android Phones [View article]
So... let me get this straight. Nokia is going through a bad time, posting losses... and yet, they are ready to triple the size of their software team to port all their apps to yet another OS?
Sorry but I only see Nokia betting on Android after they are steadily making money again. Until then, it's a gamble Elop will not take.
'Bye, Bye, Nokia' Or 'Buy, Buy, Nokia'? [View article]
Nokia And Sprint: Great Potential For Turnaround [View article]
But then again, CRUS only goes up, while Salesforce.com keep on losing money. Makes no sense whatsoever.
McDonald's, I'm Not Lovin' Its Zero U.S. Sales Growth [View article]
Or Salesforce, a company that only loses money but its stock only goes up?
Then you have growing companies, with profits rising, which get no love from WS and their stock is constantly ravaged?
Angela Merkel calls herself "very satisfied" a Cyprus solution has been found and reminds taxpayers cannot save banks (Ireland and Spain say "hi"). "With responsibility on the part of Cyprus, we will ensure that solidarity is provided by the euro are," says EU Commission chief Barroso. Meanwhile, the WSJ reports Cyprus border officials searching bags with orders to confiscate any cash sums over €10K. Just a reminder - Cyprus is a member of the EU. [View news story]
Poor cash flow trends for Nokia's (NOK -0.7%) phone business are being masked by the strong performance of a resurgent Nokia Siemens, argues BofA/Merrill, which reiterates an Underperform. Should a spinoff, sale, or IPO of NSN happen following the pending expiration of Nokia and Siemens' JV agreement (as many expect), the firm thinks Nokia's handset cash flow challenges will become more apparent. [View news story]
Cramer Is Now Bullish On 'Old Tech' Stocks Like Intel [View article]
I'll keep waiting for that day when INTC will drop 30% after-hours so I can start buying it.
PS: I still remember the Summer of 2011, where Cramer recommended buying RIMM around $50, saying it would popup to $70 in no time. Instead, RIMM went the other way, until $7. At least he got the "No time" part right.
Cisco Systems: Absolutely The Best Tech Bet In 2013? [View article]
I still remember HPQ trading at $35, which had an "Intrinsic Value" of $48 in the summer of 2011... and then it crashed to $26... and then it crashed again to $11...
At that time, no analyst was pointing to a value below $37. How well has that worked out?
Ditch The Euro, But Not Just Yet [View article]
In Europe is being privatized, including schools, hospitals & water.
You must have a strange definition of socialism, that's for sure... or you live in an alternate reality.
Once Again, Nokia Gets Downgraded By Goldman Sachs [View article]
On August 2, 2012 Goldman Sachs cut its rating on Nokia from Neutral to Sell, with a price target of €1.30 ($1.60 per ADR).
So how can the same firm cut NOK Price Target from $4.8 to $3.5?
In reality this was a PT increase, wasn't it!?
A Quick Look At 8 Biotechs Ready To Gain Momentum [View article]
Spectrum Pharmaceuticals (SPPI) guides FY13 revenue below Street estimates, now anticipating total revenues in the range of $160M to $180M. Analysts were projecting FY13 revenue to come in at $297M. The company cites a change in ordering patterns of Fusilev and an increase in generic competition in its hospital segment for the shortfall, following the recent stabilization of the folate analog market. Shares remain halted AH. [View news story]
Spectrum Pharmaceuticals Provides Corporate Update [View article]
I hope he quits. After this, no investor will ever trust anything he says.
I'm long SPPI and I won't sell but this price is perfectly justified. I see it going back to $4... but I'd rather hold now than taking a loss. I feel cheated but I'll wait for 5 decades to recover my money, if I have to.
Spectrum Pharmaceuticals (SPPI) guides FY13 revenue below Street estimates, now anticipating total revenues in the range of $160M to $180M. Analysts were projecting FY13 revenue to come in at $297M. The company cites a change in ordering patterns of Fusilev and an increase in generic competition in its hospital segment for the shortfall, following the recent stabilization of the folate analog market. Shares remain halted AH. [View news story]
Spectrum Pharmaceuticals (SPPI): Q4 EPS of $0.27 beats by $0.01. Revenue of $70.1M beats by $0.22M. (PR) [View news story]
Nokia Will Probably Launch Android Phones [View article]
Sorry but I only see Nokia betting on Android after they are steadily making money again. Until then, it's a gamble Elop will not take.